USPTO Trademark Application for PR PDRN (POLYDEOXYRIBONUCLEOTIDE SODIUM) 10 G
Summary
The USPTO has received an intent-to-use trademark application for 'PR PDRN (POLYDEOXYRIBONUCLEOTIDE SODIUM) 10 G'. The application covers pharmaceutical preparations for skin care, including medicated creams and ointments for dermatological use and treating skin disorders.
What changed
The United States Patent and Trademark Office (USPTO) has published an intent-to-use trademark application (TM99492708) for the mark 'PR PDRN (POLYDEOXYRIBONUCLEOTIDE SODIUM) 10 G'. The application, filed on November 12, 2025, seeks to register the mark for a range of pharmaceutical preparations for skin care, including medicated creams, ointments for dermatological use, anti-itch ointments, and antiseptic ointments.
This filing represents a new trademark application and does not impose any immediate compliance obligations. However, it signals potential market entry or brand expansion for the applicant in the pharmaceutical and dermatological sectors. Companies operating in these areas should be aware of this new mark as it may affect future branding and product naming strategies.
Archived snapshot
Mar 24, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
← USPTO Trademark Applications
PR PDRN (POLYDEOXYRIBONUCLEOTIDE SODIUM) 10 G
Intent to Use TM99492708 Kind: intenttouse Mar 22, 2026
Abstract
Pharmaceutical preparation for skin care; Medicated skin preparation for use in treating skin disorders; Creams for dermatological use; Medicated creams for treating dermatological conditions; Medicinal creams for skin care; Anti-itch ointment; Medicated body care preparations, namely, antiseptic ointments; Medicated body care preparations, namely, ointments for pharmaceutical purposes
Filing Date
2025-11-12
Related changes
Get daily alerts for USPTO Trademarks - Pharmaceuticals (Class 005)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Trademarks - Pharmaceuticals (Class 005) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.